These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37928768

  • 21. Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study.
    Said A, Esmail M, Abdel Naiem E, Zaki Z, Raouf R.
    Adv Respir Med; 2021; 89(4):369-377. PubMed ID: 34494240
    [Abstract] [Full Text] [Related]

  • 22. Relationship between airway wall thickness assessed by high-resolution computed tomography and lung function in patients with asthma and chronic obstructive pulmonary disease.
    Kosciuch J, Krenke R, Gorska K, Zukowska M, Maskey-Warzechowska M, Chazan R.
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():71-6. PubMed ID: 20134043
    [Abstract] [Full Text] [Related]

  • 23. Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
    Nuñez A, Marras V, Harlander M, Mekov E, Esquinas C, Turel M, Lestan D, Petkov R, Yanev N, Pirina P, Negri S, Miravitlles M, Barrecheguren M.
    Int J Chron Obstruct Pulmon Dis; 2020 Nov; 15():681-690. PubMed ID: 32280207
    [Abstract] [Full Text] [Related]

  • 24. Increased Epicardial Adipose Tissue Is Associated with the Airway Dominant Phenotype of Chronic Obstructive Pulmonary Disease.
    Higami Y, Ogawa E, Ryujin Y, Goto K, Seto R, Wada H, Tho NV, Lan le TT, Paré PD, Nakano Y.
    PLoS One; 2016 Nov; 11(2):e0148794. PubMed ID: 26866482
    [Abstract] [Full Text] [Related]

  • 25. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M, Lykkegaard J, Halling A, Vestbo J, Søndergaard J, Pottegård A.
    NPJ Prim Care Respir Med; 2017 Apr 17; 27(1):25. PubMed ID: 28416794
    [Abstract] [Full Text] [Related]

  • 26. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.
    Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF.
    Respir Res; 2013 Oct 29; 14(1):116. PubMed ID: 24168767
    [Abstract] [Full Text] [Related]

  • 27. Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype.
    Montiel AM, Ruiz-Esteban P, Del Río AD, Valdivielso P, Chaparro MÁS, Olveira C.
    Sci Rep; 2024 Apr 27; 14(1):9687. PubMed ID: 38678074
    [Abstract] [Full Text] [Related]

  • 28. Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study.
    Gulati S, Wells JM, Urdaneta GP, Balestrini K, Vital I, Tovar K, Barnes JW, Bhatt SP, Campos M, Krick S.
    Int J Mol Sci; 2019 May 09; 20(9):. PubMed ID: 31075857
    [Abstract] [Full Text] [Related]

  • 29. Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.
    Yang HM, Ryu MH, Carey VJ, Kinney GL, Hokanson JE, Dransfield MT, Hersh CP, Silverman EK, COPDGene Investigators †.
    J Am Heart Assoc; 2024 Jun 04; 13(11):e033882. PubMed ID: 38818936
    [Abstract] [Full Text] [Related]

  • 30. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.
    Respir Med; 2015 Feb 04; 109(2):228-37. PubMed ID: 25613107
    [Abstract] [Full Text] [Related]

  • 31. Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype.
    Pragman AA, Hodgson SW, Wu T, Zank A, Reilly CS, Wendt CH.
    ERJ Open Res; 2024 Jan 04; 10(1):. PubMed ID: 38333651
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.
    Wedzicha JA, Brill SE, Allinson JP, Donaldson GC.
    BMC Med; 2013 Aug 14; 11():181. PubMed ID: 23945277
    [Abstract] [Full Text] [Related]

  • 33. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.
    Ding HZ, Wang H, Wu D, Zhou FC, Zhu J, Tong JB, Gao YT, Li ZG.
    Mol Med Rep; 2024 Aug 14; 30(2):. PubMed ID: 38873983
    [Abstract] [Full Text] [Related]

  • 34. Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung Cancer.
    Demiri S, Lorut C, Rabbat A, Luu van Lang D, Lefebvre A, Regnard JF, Samama CM, Dusser D, Roche N, Alifano M.
    COPD; 2018 Aug 14; 15(4):361-368. PubMed ID: 30375895
    [Abstract] [Full Text] [Related]

  • 35. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study.
    Kim V, Davey A, Comellas AP, Han MK, Washko G, Martinez CH, Lynch D, Lee JH, Silverman EK, Crapo JD, Make BJ, Criner GJ, COPDGene® Investigators.
    Respir Res; 2014 Apr 27; 15(1):52. PubMed ID: 24766722
    [Abstract] [Full Text] [Related]

  • 36. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK.
    Immunol Lett; 2018 Apr 27; 196():1-10. PubMed ID: 29329680
    [Abstract] [Full Text] [Related]

  • 37. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
    Fortis S, Wan ES, Kunisaki K, Eyck PT, Ballas ZK, Bowler RP, Crapo JD, Hokanson JE, Wendt C, Silverman EK, Comellas AP.
    Respir Med X; 2021 Nov 27; 3():. PubMed ID: 35911870
    [Abstract] [Full Text] [Related]

  • 38. Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics.
    Zhu D, Dai H, Zhu H, Fang Y, Zhou H, Yang Z, Chu S, Xi Q.
    Respir Med; 2023 Apr 27; 209():107150. PubMed ID: 36758904
    [Abstract] [Full Text] [Related]

  • 39. Association of Total Airway Count on Computed Tomography with Pulmonary Function Decline in Early-Stage COPD: A Population-Based Prospective Cohort Study.
    Wu F, Jiang C, Zhou Y, Zheng Y, Tian H, Li H, Deng Z, Zhao N, Chen H, Ran P.
    Int J Chron Obstruct Pulmon Dis; 2021 Apr 27; 16():3437-3448. PubMed ID: 34984001
    [Abstract] [Full Text] [Related]

  • 40. [Correlation between pulmonary quantitative CT measurement indicators and respiratory symptoms in patients with chronic obstructive pulmonary disease in stable stage].
    Wang YX, Sun TY, Li YM, Zhang M, Wang GX, Chen QH, Guo YF.
    Zhonghua Yi Xue Za Zhi; 2023 Oct 17; 103(38):3017-3025. PubMed ID: 37813652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.